CHS - FXDFR PRF PERPETUAL USD 25 - Ser 2 Cls B EBIT

As of the most recent data (May 2026), CHSCN shows a EBIT of $520M. That compares with $260M in the prior-year period — up 101.2% year over year. That is below the Industrials sector average of $40B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHSCN's EBIT is now $520M (was $260M) — a 101.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CHS - FXDFR PRF PERPETUAL USD 25 - Ser 2 Cls B is outperforming or lagging.

The Industrials sector average EBIT is about $40B. CHS - FXDFR PRF PERPETUAL USD 25 - Ser 2 Cls B is at $520M, which is lower that average. That is roughly 98.7% below the sector mean. Use the comparison chart on this page to see how CHSCN stacks up against individual peers as well.

Tracking CHSCN's ebit over time shows whether CHS - FXDFR PRF PERPETUAL USD 25 - Ser 2 Cls B is scaling, shrinking, or reshaping that part of the business. The current reading is $520M That compares with $260M in the prior-year period — up 101.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has CHS - FXDFR PRF PERPETUAL USD 25 - Ser 2 Cls B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $520M) with ownership activity and broader fundamentals.